Almost all SOX genes, for instance, SOX1, SOX2, SOX7, and SOX10, have been found to have the potential to regulate the progression of glioma, whose expression levels are also related to the prognosis of patients (9–12). The gene discussed is SOX10; the disease is central nervous system cancer.